Kenneth Micklethwaite

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

Kenneth Micklethwaite, Barbara Savoldo, Carlos A. Ramos et al. · Blood · 2013 · 506 citations · Full text

Medicine, Hematology, Immunology +14

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Emily Blyth, Leighton Clancy, Renee Simms et al. · Blood · 2013 · 231 citations

Medicine, Immunology, Pharmacotherapy +16

Investigation of product-derived lymphoma following infusion of <i>piggyBac</i>-modified CD19 chimeric antigen receptor T cells

Kenneth Micklethwaite, Kavitha Gowrishankar, Brian Gloss et al. · Blood · 2021 · 214 citations · Full text

Life Sciences, Immunology, Oncology +12

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Barbara Withers, Emily Blyth, Leighton Clancy et al. · Blood Advances · 2017 · 141 citations · Full text

Medicine, Hematology, Immunology +17

Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell Transplantation

Kenneth Micklethwaite, Anna M. Hansen, Aaron E. Foster et al. · Biology of Blood and Marrow Transplantation · 2007 · 132 citations · Full text

Life Sciences, Hematology, Immunology +17